Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04310436
Other study ID # ITSligo HMcD
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 10, 2020
Est. completion date September 2, 2021

Study information

Verified date April 2020
Source Institute of Technology, Sligo
Contact Kenneth Monaghan, PhD
Phone 00353879480448
Email monaghan.kenneth@itsligo.ie
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a pilot randomised controlled trial investigating whether using modification of saccadic eye movements can control lateral unconscious tongue positioning and enhance fluency in adults with a confirmed developmental stammer. This study is being conducted as part of an MSc by research qualification at the Institute of Technology Sligo in Ireland with a view to extending to PhD. The setting is home setting with all assessments either taking place at home via video link or in the institute. The study is being conducted in conjunction with the Community Speech and Language Therapist and has attained ethical approval through Sligo University Hospital (SUH) Ethics Committee.


Description:

Participants will be assessed for stammering severity either on line via video link or in the Institute of Technology Sligo Health Science & Exercise Physiology Lab (B2004) at three time points: before intervention, after a five-week trial period and three months post completion. Participants will complete two assessments at each time to cater for "off" days. Participants will be required to practice quick eye movements at the start of words / syllables where dysfluencies are predicted for 10 minutes twice a day for the treatment period. Training in eye movement (saccade) modification will occur following the initial assessment in IT Sligo, or video link.

Participants will be assigned to one of two treatment arms. An experimental arm, and a control (placebo) arm. All participants will be assessed regarding their premonitory awareness of anticipated dysfluencies both before training and at the three month Based on advice from Community Speech and language Manager (Ms Sinead Carthy), participants will voice/video message the principle investigator once per week for this five-week period to confirm compliance.


Recruitment information / eligibility

Status Recruiting
Enrollment 60
Est. completion date September 2, 2021
Est. primary completion date December 10, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults age > 18 years.

- A diagnosis of confirmed developmental stammer from SALT characterized by stammering on = 3% of syllables.

- A proficiency in the English Language.

- No diagnosis of any emotional, behavioural, learning or neurological disorder.

- Cognitive ability to take part.

- Have previously completed a course of outpatient treatment for confirmed developmental stammer.

Exclusion Criteria:

- Younger than 18 years.

- Not having completed a traditional intervention for stammer.

- This research is not intended to replace current interventions but provide additional possibilities for those adults who have completed a standard programme of intervention and their developmental stammer still persists and a rate of = 3% of syllables

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Modifying saccades by looking down to naval.
Paragraphs from list Provided by Researcher. Participants to read out loud for 10 minutes twice per day for the five week period. On any word they anticipate / experience dysfluencies look quickly down to their naval to reset the lateral tongue position.
Modifying saccades by looking in air.
Paragraphs from list provided by Researcher. Participants to read out loud for 10 minutes twice per day for the five week period. On any word they anticipate / experience dysfluencies look quickly up to reset the lateral tongue position.

Locations

Country Name City State
Ireland Institute of Technology, Sligo Sligo Co Sligo

Sponsors (2)

Lead Sponsor Collaborator
Institute of Technology, Sligo Irish Research Council

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Stammering Severity (SSI-4) (Howell et. al. 2011). Measures stuttering severity in adults and children. It measures the percentage of stuttered syllables versus fluent speech in the participant. It also measures the frequency of repetition and prolongations, duration of blocks, and physical concomitants. 10 minutes.
Secondary Stammering Experience Overall Assessment of the Speaker's Experience of Stuttering OASES-A (Yaruss & Quesal 2006). Measures the impact of stuttering on a person's life. Scores range between 1 (Mild) and 5 (Severe). The impact is broken down to four sections: General Information, Speaker's reactions, Daily Communication and Quality of life. There is also an overall impact score. 10 minutes.
Secondary Premonitory Awareness in Stuttering Scale (PAiS) (Cholin et. al. 2016). Measures the anticipation effect in stuttering. 14 items assessing premonitory awareness of stuttering sensation to assess the individual's capacity, manner and style of anticipation. Each item consists of a 4-point Likert scale ranging from "not at all" to "very much". A higher score indicates a larger anticipation of stuttering by the participant. 10 minutes.
See also
  Status Clinical Trial Phase
Recruiting NCT05339906 - Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band N/A
Recruiting NCT04813588 - Comparison of Pantomiming and Easy Onset Treatment N/A
Completed NCT00945113 - Pilot: Group Therapy for Children Who Stammer N/A
Completed NCT05574803 - High-definition tDCS Treatment for Cantonese-speaking Adults Who Stutter N/A